Copying and distributing are prohibited without permission of the publisher.


Rottapharm plans debut high yield bond as step towards IPO

05 Nov 2012

Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
05 Nov 2012